Abstract:Background and Purpose Muscle loss is a common complication in patients with heart failure (HF) associated with a significant increase in morbidity and mortality. Myokines (muscle proteins) play a crucial role in the pathophysiology of the disease; in particular, an imbalance in myostatin and follistatin has been reported. Although strength training (ST) within a cardiac rehabilitation (CR) program can modulate the expression of these myokines, its effect in patients with HF with preserved ejection fraction (HFpEF) is unknown. We hypothesize that in this population, ST with high load and low repetitions can mitigate muscle cachexia with better myiokine overexpression in this population. Our objective is to evaluate the impact of a CR program with emphasis on high-load, low-repetition ST on the regulation of these muscle proteins, muscle gain and cardiorespiratory fitness (CRFit) in patients with HFpEF. Methods Quasi-experimental study of a CR program (24 sessions of 90 minutes, 3 times a week, for 8 weeks), with the following structure: warm-up (10 minutes), 30-minute ST of high loads (>85% maximum repetition, 1MR) with low repetitions (3-5) and rest times between sets of 2 minutes; then 30 minutes of aerobic resistance training at moderate intensity (60-80% of maximum heart rate) and finally breathing exercises and cool-down (10 minutes). Myokines were determined by immunoassays. Muscular strength was determined by 1MR in biceps, triceps, lateral deltoid, quadriceps, hamstrings, gastrocnemius and soleus. For CRFit, maximum oxygen consumption (VO2) was measured and six-minute walk test protocol was also performed. Pre and post-intervention comparison was made using paired t test, Pearson's correlation was used in data analysis and a value of p<0.05 was considered significant. Results 59 patients were admitted, of which 8 of them left due to decompensation. Of the remaining 51 (62.7% male), the mean age was 66±8 years, all of them with HFpEF (M:55±2.4% vs W:54±2.1%; p=0.743). The other diagnoses in the study population were myocardial revascularization (52.94%), angioplasty (29.41%), valve replacement (11.6%), arterial hypertension (60%) and obesity (35%). After CR program it was observerd an improvement in VO2 (from 9.95±2.6 to 13.32±1.7; p=0.022) and meters traveled (243±41 to 349±14; p=0.002), and a decrease in myostatin levels (3337.1±69.2 to 2448.0±70.6; p=0.001) and elevation of follistatin (2167.4±96.9 to 3231.6±67.7; p=0.001). We found a strong positive correlation between follistatin levels and muscle percentage (r=0.8947 Pearson, graph1) and a strong negative correlation with myostatin and muscle percentage (r= -0.8034 Pearson, graph2). Conclusion A phase II CR program with a ST component based on high loads and low repetitions improved muscle strength and mass, FitCR and distance traveled in patients with HFpEF, without modify hemodynamic function. Follistatin levels increased by 49.09% and myostatin levels decreased by 26.65%.

Myostatin serum concentration as an indicator for deviated muscle metabolism in severe burn injuries

Molecular mechanisms of post‐burn muscle wasting and the therapeutic potential of physical exercise

1H-nuclear magnetic resonance analysis reveals dynamic changes in the metabolic profile of patients with severe burns

Comparison of Fatty Acid and Gene Profiles in Skeletal Muscle in Normal and Obese C57BL/6J Mice Before and after Blunt Muscle Injury

21 Untargeted Metabolomics Analysis: A Candidate Biomarker and Prognostic Tool in Burn Injury

Association Between Serum Myostatin Levels, Hospital Mortality, and Muscle Mass and Strength Following ST-Elevation Myocardial Infarction

The influence of Muscle Wasting on Patient Outcomes among Burn Patients: A Burn Care Quality Platform Study

Evaluation of Serum Myostatin Concentration in Chronic Heart Failure with Preserved and Impaired Left Ventricular Ejection Fraction

Deficiency of myostatin protects skeletal muscle cells from ischemia reperfusion injury

Circulating myostatin levels as a prognostic biomarker in patients with acute liver failure and late‐onset hepatic failure

Respiratory Muscle Contraction Characteristics and Potential Mechanisms in Severely Burned Rats

Expression of myostatin and folistatin as a response to high-load strength training to counteract the loss of muscle mass in heart failure with preserved ejection fraction

Nonsevere Burn Induces a Prolonged Systemic Metabolic Phenotype Indicative of a Persistent Inflammatory Response Postinjury

Therapeutic applications and challenges in myostatin inhibition for enhanced skeletal muscle mass and functions

Myosteatosis: an underrecognized risk factor for mortality in non-dialysis chronic kidney disease patients

A novel perspective for burn-induced myopathy: Membrane repair defect

Acute Muscle Wasting Rate Assessment and Long-Term Mortality in Critically Ill Trauma.

Stomatin promotes neutrophil degranulation and vascular leakage in the early stage after severe burn via enhancement of the intracellular binding of neutrophil primary granules to F-actin

Title efficacy of phosphodiesterase 5 inhibitor on distant burn-induced muscle autophagy, microcirculation, and survival rate

521 Assessing the Utility of Visceral Proteins as Markers of Nutrition

Association of Longitudinal Changes in Skeletal Muscle Mass with Prognosis and Nutritional Intake in Acutely Hospitalized Patients with Abdominal Trauma: a Retrospective Observational Study